Point72 Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,267,958
| Closed | -$40.5M | – | 1262 |
|
|
2024
Q4 | $40.5M | Buy |
+1,267,958
| New | +$40.5M | 0.09% | 247 |
|
|
2024
Q2 | – | Sell |
-267,823
| Closed | -$15.7M | – | 1192 |
|
|
2024
Q1 | $15.7M | Buy |
+267,823
| New | +$15.7M | 0.04% | 483 |
|
|
2023
Q3 | – | Sell |
-1,239,361
| Closed | -$113M | – | 1757 |
|
|
2023
Q2 | $113M | Sell |
1,239,361
-640,363
| -34% | -$58.3M | 0.34% | 60 |
|
|
2023
Q1 | $124M | Buy |
+1,879,724
| New | +$124M | 0.38% | 49 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1010 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 972 |
|
|
2021
Q2 | – | Sell |
-250,000
| Closed | -$10.7M | – | 903 |
|
|
2021
Q1 | $10.7M | Buy |
250,000
+226,600
| +968% | +$9.72M | 0.05% | 393 |
|
|
2020
Q4 | $1.34M | Sell |
23,400
-423,536
| -95% | -$24.2M | 0.01% | 736 |
|
|
2020
Q3 | $13.5M | Buy |
446,936
+238,833
| +115% | +$7.21M | 0.07% | 326 |
|
|
2020
Q2 | $6.8M | Sell |
208,103
-112,198
| -35% | -$3.66M | 0.04% | 400 |
|
|
2020
Q1 | $8.58M | Buy |
+320,301
| New | +$8.58M | 0.07% | 306 |
|
|
2019
Q3 | – | Sell |
-401,104
| Closed | -$10.2M | – | 1063 |
|
|
2019
Q2 | $10.2M | Buy |
401,104
+67,475
| +20% | +$1.71M | 0.05% | 329 |
|
|
2019
Q1 | $6.51M | Buy |
333,629
+222,613
| +201% | +$4.34M | 0.03% | 434 |
|
|
2018
Q4 | $1.46M | Buy |
+111,016
| New | +$1.46M | 0.01% | 667 |
|